Analgesics Market: North America to Remain Largest Revenue Market Throughout the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028
- REP-GB-1306
- 2018-08-10
- Category: Healthcare, Pharmaceuticals and Medical devices
- 360 Pages
- Format:
Market Value and Forecast
The global analgesics market is expected to expand at a CAGR of 5.0% over the forecast period 2018–2028. The global analgesics market is expected to be dominated by North America with 49.0% revenue share in 2018.
Regional Outlook
Geographically, the global analgesics market is expected to be dominated by North America due to increasing burden of pain management and adoption of premium-priced opioids. The growing number of surgeries and prevalence of cancer coupled with penetration of effective pain management medications are the other factors expected to fuel the growth of the analgesics market in the region.
By country, the U.S. is expected to be the most lucrative analgesics market followed by China. According to the National Institute of Health (NIH) and Centers for Disease Control and Prevention (CDC), more than 30% of Americans are living with some form of chronic or severe pain. The reimbursement scenario for pain management medications in the U.S. is further expected to fuel the growth of the analgesics market. Higher penetration of analgesics drugs for pain management coupled with higher treatment seeking rate is expected to drive the growth of the U.S. analgesics market over the forecast period. China is expected to be second large market for analgesics due to increasing number of surgical procedures as well as prevalence of cancer and neuropathic pain. Usually, non-steroidal anti-inflammatory drugs (NSAIDs) are used in China for pain management, but from the last decade the adoption of opioids for pain management has increased at a significant rate. Besides, extended efforts are been made by various analgesics manufacturers to increase their market footprints by undergoing collaborations, partnerships, mergers and acquisitions with local analgesics drug manufacturers, e.g., Purdue Pharma L.P. and Mundipharma International extended their opioid product portfolio in China in 2014 and 2018, respectively.
In terms of revenue share, Canada, Germany and France stand at the third, fourth and fifth place, respectively, in the analgesics market. By region, Western Europe is expected to be the second large analgesics market due to high penetration of analgesics for pain management. Asia Pacific is expected to witness fastest CAGR of 8.0% (2018-2028) owing to increasing adoption of advanced pain care drugs, government initiatives to spread awareness and various welfare schemes. Less availability and affordability of high efficacy drugs, such as opioid analgesics, is expected to hamper the growth of analgesics market in Asia Pacific. The Middle East and Africa is the least lucrative analgesics market due to low adoption of pain management medications. Latin America is experiencing a steady growth, but is expected to be less lucrative analgesics market due to undertreatment of pain.
Key Insights
-
Favourable reimbursement scenario in North America and Western Europe for pain management, particularly for patients with cancer pain and inpatient pain, is expected to drive the growth of the analgesics market in the regions over the forecast period.
-
The North America analgesics market size is expected to represent a high incremental opportunity of US$ 1,476.5 in 2018 over 2017
-
Various non-opioid analgesics to treat moderate to chronic pain are under the development phase due to increased abusive consumption of opioid drugs for non-medical purpose
-
Various manufacturers are developing opioids with abuse deterrence properties to reduce the abusive consumption of opioids for non-medical purpose, which is expected to contribute to the growth of the analgesics market.
-
Asia Pacific is expected to the fast-growing analgesics market due to growing pain treatment seeking rate.
-
Various analgesics manufacturers are focusing on to expand their market footprints by undergoing collaborations, mergers & acquisitions, partnerships with local analgesics manufacturers, e.g., Grunenthal and Mundipharma have entered into a license and distribution agreement, under which Mundipharma will promote and distribute Grunenthal’s tramal (tramadol) in China from May 1, 2018.
Factors and Trends Impacting the Growth of the Market
-
The number of cancer cases is increasing and so is the prevalence of cancer pain, which is expected to drive the demand for analgesics over the forecast period.
-
During 1999–2015, abusive consumption of opioid analgesics for non-medical purpose resulted in more than 183,000 deaths in the U.S.
-
Various opioid manufacturing companies withdrew their products and stopped the promotion of opioids, e.g. Endo International plc voluntarily stopped promoting opioid products to the U.S. healthcare professionals and eliminated the company’s entire U.S. pain product sales force. Endo also voluntarily withdrew Opana ER from the analgesics market. Purdue Pharma L.P. restructured and significantly reduced their commercial operation, and announced that their sales representatives will no longer promote opioids to prescribers.
-
Undertreatment of cancer pain is a major challenge in the Asian countries, where the percentage of patients with negative pain management index (PMI), which represents the degree of undertreatment of pain, ranged from 27.0% to 79.0%. Whereas, the U.S. (39.1–3%) and Europe (19.1–26.6%) have lower mean negative PMI.
This Future Market Insights (FMI) report examines the ‘Global Analgesics Market’ for the period 2018–2028. The primary objective of the report is to offer updates and information related to market opportunities in the global analgesics market.
The Analgesics Market is Segmented Based on:
-
Drug Class
-
Pain Type
-
Distribution Channel
-
Region
This report covers the global analgesics market performance in terms of revenue contribution from various segments. The global analgesics market report begins with an overview and its definitions. The market viewpoints section underlines macro-economic factors influencing the growth of the global analgesics market along with detailing the opportunity analysis of the market. This is then followed by the key market drivers, restraints and trends.
When considering the analgesics market, it is split by prescription and over-the-counter (OTC) analgesics. Each segment of the global analgesics market is tracked by prescription and OTC revenue generation.
By drug class, the global analgesics market is segmented as opioids, non-steroidal anti-inflammatory drugs (NSAIDs), local anaesthetics and acetaminophen. The drug class segment is analysed by both prescription analgesics and OTC analgesics. Opioids is expected to remain the dominant segment due to their higher efficacy in pain management. The premium price of opioid also helps it to generate more revenue as compared to other types of analgesics. The adoption of opioid analgesics is higher in North America and Western Europe due to reimbursements and easy availability. Whereas, NSAIDs analgesics are highly adopted in Asia-Pacific, Eastern Europe and Latin America.
By pain type, the global analgesics market is segmented as surgical pain, cancer pain, neuropathic pain and other types of pain. The surgical pain is expected to be the dominant segment in the global analgesics market followed by cancer pain and neuropathic pain, respectively. This segment is also split into prescription analgesics and OTC analgesics.
By distribution channel, the global analgesics market is segmented into hospital pharmacies, retail pharmacies, drug stores, clinics and others. This considers revenue generation by prescription analgesics and OTC analgesics separately.
By region, the global analgesics market has been segmented into North America (the U.S. & Canada), Latin America (Brazil, Mexico, and Rest of Latin America), Western Europe (Germany, France, the U.K., Italy, Spain and Rest of Western Europe), Eastern Europe (Russia, Poland and Rest of Eastern Europe), Asia Pacific excluding China and Japan (India, Australia & New Zealand and Rest of Asia Pacific), China, Japan and Middle East and Africa (GCC Countries, South Africa and Rest of MEA). Each country and region in the report provides revenue generation by prescription analgesics and OTC analgesics within the forecast period.
A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and market attractive index. The forecast of the analgesics market by country, drug class, pain type and distribution channel is represented in a tabular form for each region. This section will help to understand the present scenario and opportunity of the analgesics market in major countries by each segment.
In the next section of the report, the ‘Competitive Landscape’ is included to provide report audiences with a dashboard view of the key competitor firms in order to access the key differentiators among the competitor firms. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to a market segment. The detailed profiles of players operating in the analgesics market are also provided in the report, which highlight company description, product/segment overview, SWOT analysis, financial information, key developments related to the analgesics market and the strategic overview.
The next section of the report highlights the market outlook for 2018–2028 and sets the forecast within the context of the analgesics market by region.
The above sections – by drug class, pain type and distribution channel – evaluate the historic market analysis and growth prospects of the analgesics market for the period 2018–2028. We have considered 2017 as the base year and provided data for the forecast period.
The final section of the report represents the global scenario of the analgesics market along with y-o-y growth and market forecast till 2028. This section also evaluates the global market opportunity over the forecast period as well as the absolute dollar opportunity for each year. This section will help to understand the overall market growth for analgesics and the opportunity analysis for every year over the forecast period.
To arrive at the market size, bottom-up approach is used to validate the total market size obtained for the analgesics market. The forecast presented in the report provides total revenue of the analgesics market over 2018–2028. FMI uses the triangulation methodology, which is primarily based on experimental techniques such as patient-level data to obtain precise market estimations for the analgesics market and insights on specific country/regions. The country-specific data is again analysed to derive data at a regional level and then at a global level. This methodology ensures high quality and accuracy of information.
The factors considered while developing the estimates of the analgesics market are epidemiology, treatment seeking rate, ratio of population prescribed with different analgesics.
On the other hand, FMI has also analysed the market by considering the revenue from the key players operating in the market. The key players are segmented at a Tier-level with respect to their revenues, product portfolio and geographical presence. This process involves analysis of annual reports of various companies, investor presentations, SEC filings, 10k reports, earning call transcripts and press releases. This task is done to fetch substantial information about the key players, their respective revenues and estimate their respective market share.
The revenue growth of the key market players is analysed over the historical period and qualitative assessment of new product launches and innovations has been made in order to validate and align the resultant market numbers. The market structure is closely studied and analysed at a regional level to map and ascertain incremental $ opportunity for companies, for instance, supply from domestic/regional players, small-scale enterprises or unorganized segments is also taken into consideration to arrive at the final market numbers.
While forecasting the market size for the analgesics market, we have considered the impact of several factors such as per capital healthcare expenditure, disposable income, new analgesics and approvals for new advanced analgesics, penetration of analgesics through various distribution channels, and generic penetration across all regions, among others. However, quantifying the analgesics market across the aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities rather than rationalizing them after the forecast has been completed. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the analgesics market and to identify the right growth opportunities in the global analgesics market
Analgesics Market Reports - Table of Contents
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Analgesics Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Trends
5. Global Economic Outlook
5.1. Gross Domestic Product by Region & Country, 2006 – 2021
6. Key Inclusions
6.1. PEST Analysis
6.2. Key Regulations: Opioids
6.3. Opioid Consumption : Fast Fact
7. North America Analgesics Market Analysis 2013–2017 and Forecast 2018–2028
7.1. Introduction
7.2. Historical Market Value (US$ Mn) Analysis By Country, 2013–2017
7.2.1. U.S.
7.2.2. Canada
7.3. Market Value (US$ Mn) Forecast By Country, 2018–2028
7.4. Historical Market Value (US$ Mn) Trend Analysis By Drug Class, 2013–2017
7.4.1. Opioids
7.4.2. NSAIDs
7.4.3. Local Anesthetics
7.4.4. Acetaminophen
7.5. Market Value (US$ Mn) Forecast By Drug Class, 2018–2028
7.6. Historical Market Value (US$ Mn) Trend Analysis By Pain Type, 2013–2017
7.6.1. Surgical Pain
7.6.2. Cancer Pain
7.6.3. Neuropathic Pain
7.6.4. Others
7.7. Market Value (US$ Mn) Forecast By Pain Type, 2018–2028
7.8. Historical Market Value (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
7.8.1. Injectable
7.8.2. Oral
7.8.3. Topical
7.8.4. Transdermal
7.8.5. Others
7.9. Market Value (US$ Mn) Forecast By Route of Administration, 2018–2028
7.10.Historical Market Value (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
7.10.1. Hospital Pharmacies
7.10.2. Retail Pharmacies
7.10.3. Drug Store
7.10.4. Clinics
7.10.5. Others
7.11.Market Value (US$ Mn) Forecast By Distribution Channel, 2018–2028
7.12.Market Attractiveness Analysis
7.12.1. By Country
7.12.2. By Drug Class
7.12.3. By Pain Type
7.12.4. By Route of Administration
7.12.5. By Distribution Channel
7.13.Drivers and Restraints – Impact Analysis
8. Western Europe Analgesics Market Analysis 2013–2017 and Forecast 2018–2028
8.1. Introduction
8.2. Historical Market Value (US$ Mn) By Country, 2013–2017
8.2.1. Germany
8.2.2. France
8.2.3. U.K.
8.2.4. Spain
8.2.5. Italy
8.2.6. Rest of Western Europe
8.3. Market Value (US$ Mn) Forecast By Country, 2018–2028
8.4. Historical Market Value (US$ Mn) Trend Analysis By Drug Class, 2013–2017
8.4.1. Opioids
8.4.2. NSAIDs
8.4.3. Local Anesthetics
8.4.4. Acetaminophen
8.5. Market Value (US$ Mn) Forecast By Drug Class, 2018–2028
8.6. Historical Market Value (US$ Mn) Trend Analysis By Pain Type, 2013–2017
8.6.1. Surgical Pain
8.6.2. Cancer Pain
8.6.3. Neuropathic Pain
8.6.4. Others
8.7. Market Value (US$ Mn) Forecast By Pain Type, 2018–2028
8.8. Historical Market Value (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
8.8.1. Injectable
8.8.2. Oral
8.8.3. Topical
8.8.4. Transdermal
8.8.5. Others
8.9. Market Value (US$ Mn) Forecast By Route of Administration, 2018–2028
8.10.Historical Market Value (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
8.10.1. Hospital Pharmacies
8.10.2. Retail Pharmacies
8.10.3. Drug Store
8.10.4. Clinics
8.10.5. Others
8.11.Market Value (US$ Mn) Forecast By Distribution Channel, 2018–2028
8.12.Market Attractiveness Analysis
8.12.1. By Country
8.12.2. By Drug Class
8.12.3. By Pain Type
8.12.4. By Route of Administration
8.12.5. By Distribution Channel
8.13.Drivers and Restraints – Impact Analysis
9. Eastern Europe Analgesics Market Analysis 2013–2017 and Forecast 2018–2028
9.1. Introduction
9.2. Historical Market Value (US$ Mn) By Country, 2013–2017
9.2.1. Russia
9.2.2. Poland
9.2.3. Rest of Eastern Europe
9.3. Market Value (US$ Mn) Forecast By Country, 2018–2028
9.4. Historical Market Value (US$ Mn) Trend Analysis By Drug Class, 2013–2017
9.4.1. Opioids
9.4.2. NSAIDs
9.4.3. Local Anesthetics
9.4.4. Acetaminophen
9.5. Market Value (US$ Mn) Forecast By Drug Class, 2018–2028
9.6. Historical Market Value (US$ Mn) Trend Analysis By Pain Type, 2013–2017
9.6.1. Surgical Pain
9.6.2. Cancer Pain
9.6.3. Neuropathic Pain
9.6.4. Others
9.7. Market Value (US$ Mn) Forecast By Pain Type, 2018–2028
9.8. Historical Market Value (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
9.8.1. Injectable
9.8.2. Oral
9.8.3. Topical
9.8.4. Transdermal
9.8.5. Others
9.9. Market Value (US$ Mn) Forecast By Route of Administration, 2018–2028
9.10.Historical Market Value (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
9.10.1. Hospital Pharmacies
9.10.2. Retail Pharmacies
9.10.3. Drug Store
9.10.4. Clinics
9.10.5. Others
9.11.Market Value (US$ Mn) Forecast By Distribution Channel, 2018–2028
9.12.Market Attractiveness Analysis
9.12.1. By Country
9.12.2. By Drug Class
9.12.3. By Pain Type
9.12.4. By Route of Administration
9.12.5. By Distribution Channel
9.13.Drivers and Restraints – Impact Analysis
10. Latin America Analgesics Market Analysis 2013–2017 and Forecast 2018–2028
10.1.Introduction
10.2.Historical Market Value (US$ Mn) By Country, 2013–2017
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3.Market Value (US$ Mn) Forecast By Country, 2018–2028
10.4.Historical Market Value (US$ Mn) Trend Analysis By Drug Class, 2013–2017
10.4.1. Opioids
10.4.2. NSAIDs
10.4.3. Local Anesthetics
10.4.4. Acetaminophen
10.5.Market Value (US$ Mn) Forecast By Drug Class, 2018–2028
10.6.Historical Market Value (US$ Mn) Trend Analysis By Pain Type, 2013–2017
10.6.1. Surgical Pain
10.6.2. Cancer Pain
10.6.3. Neuropathic Pain
10.6.4. Others
10.7.Market Value (US$ Mn) Forecast By Pain Type, 2018–2028
10.8.Historical Market Value (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
10.8.1. Injectable
10.8.2. Oral
10.8.3. Topical
10.8.4. Transdermal
10.8.5. Others
10.9.Market Value (US$ Mn) Forecast By Route of Administration, 2018–2028
10.10. Historical Market Value (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
10.10.1. Hospital Pharmacies
10.10.2. Retail Pharmacies
10.10.3. Drug Store
10.10.4. Clinics
10.10.5. Others
10.11. Market Value (US$ Mn) Forecast By Distribution Channel, 2018–2028
10.12. Market Attractiveness Analysis
10.12.1. By Country
10.12.2. By Drug Class
10.12.3. By Pain Type
10.12.4. By Route of Administration
10.12.5. By Distribution Channel
10.13. Drivers and Restraints – Impact Analysis
11. Asia Pacific excluding Japan and China (APEJC) Analgesics Market Analysis 2013–2017 and Forecast 2018–2028
11.1.Introduction
11.2.Historical Market Value (US$ Mn) By Country, 2013–2017
11.2.1. India
11.2.2. Australia and New Zealand
11.2.3. Rest of APEJC
11.3.Market Value (US$ Mn) Forecast By Country, 2018–2028
11.4.Historical Market Value (US$ Mn) Trend Analysis By Drug Class, 2013–2017
11.4.1. Opioids
11.4.2. NSAIDs
11.4.3. Local Anesthetics
11.4.4. Acetaminophen
11.5.Market Value (US$ Mn) Forecast By Drug Class, 2018–2028
11.6.Historical Market Value (US$ Mn) Trend Analysis By Pain Type, 2013–2017
11.6.1. Surgical Pain
11.6.2. Cancer Pain
11.6.3. Neuropathic Pain
11.6.4. Others
11.7.Market Value (US$ Mn) Forecast By Pain Type, 2018–2028
11.8.Historical Market Value (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
11.8.1. Injectable
11.8.2. Oral
11.8.3. Topical
11.8.4. Transdermal
11.8.5. Others
11.9.Market Value (US$ Mn) Forecast By Route of Administration, 2018–2028
11.10. Historical Market Value (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
11.10.1. Hospital Pharmacies
11.10.2. Retail Pharmacies
11.10.3. Drug Store
11.10.4. Clinics
11.10.5. Others
11.11. Market Value (US$ Mn) Forecast By Distribution Channel, 2018–2028
11.12. Market Attractiveness Analysis
11.12.1. By Country
11.12.2. By Drug Class
11.12.3. By Pain Type
11.12.4. By Route of Administration
11.12.5. By Distribution Channel
11.13. Drivers and Restraints – Impact Analysis
12. Japan Analgesics Market Analysis 2013–2017 and Forecast 2018–2028
12.1.Introduction
12.2.Historical Market Value (US$ Mn) Trend Analysis By Drug Class, 2013–2017
12.2.1. Opioids
12.2.2. NSAIDs
12.2.3. Local Anesthetics
12.2.4. Acetaminophen
12.3.Market Value (US$ Mn) Forecast By Drug Class, 2018–2028
12.4.Historical Market Value (US$ Mn) Trend Analysis By Pain Type, 2013–2017
12.4.1. Surgical Pain
12.4.2. Cancer Pain
12.4.3. Neuropathic Pain
12.4.4. Others
12.5.Market Value (US$ Mn) Forecast By Pain Type, 2018–2028
12.6.Historical Market Value (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
12.6.1. Injectable
12.6.2. Oral
12.6.3. Topical
12.6.4. Transdermal
12.6.5. Others
12.7.Market Value (US$ Mn) Forecast By Route of Administration, 2018–2028
12.8.Historical Market Value (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
12.8.1. Hospital Pharmacies
12.8.2. Retail Pharmacies
12.8.3. Drug Store
12.8.4. Clinics
12.8.5. Others
12.9.Market Value (US$ Mn) Forecast By Distribution Channel, 2018–2028
12.10. Market Attractiveness Analysis
12.10.1. By Drug Class
12.10.2. By Pain Type
12.10.3. By Route of Administration
12.10.4. By Distribution Channel
12.11. Drivers and Restraints – Impact Analysis
13. China Analgesics Market Analysis 2013–2017 and Forecast 2018–2028
13.1.Introduction
13.2.Historical Market Value (US$ Mn) Trend Analysis By Drug Class, 2013–2017
13.2.1. Opioids
13.2.2. NSAIDs
13.2.3. Local Anesthetics
13.2.4. Acetaminophen
13.3.Market Value (US$ Mn) Forecast By Drug Class, 2018–2028
13.4.Historical Market Value (US$ Mn) Trend Analysis By Pain Type, 2013–2017
13.4.1. Surgical Pain
13.4.2. Cancer Pain
13.4.3. Neuropathic Pain
13.4.4. Others
13.5.Market Value (US$ Mn) Forecast By Pain Type, 2018–2028
13.6.Historical Market Value (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
13.6.1. Injectable
13.6.2. Oral
13.6.3. Topical
13.6.4. Transdermal
13.6.5. Others
13.7.Market Value (US$ Mn) Forecast By Route of Administration, 2018–2028
13.8.Historical Market Value (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
13.8.1. Hospital Pharmacies
13.8.2. Retail Pharmacies
13.8.3. Drug Store
13.8.4. Clinics
13.8.5. Others
13.9.Market Value (US$ Mn) Forecast By Distribution Channel, 2018–2028
13.10. Market Attractiveness Analysis
13.10.1. By Drug Class
13.10.2. By Pain Type
13.10.3. By Route of Administration
13.10.4. By Distribution Channel
13.11. Drivers and Restraints – Impact Analysis
14. MEA Analgesics Market Analysis 2013–2017 and Forecast 2018–2028
14.1.Introduction
14.2.Historical Market Value (US$ Mn) By Country, 2013–2017
14.2.1. GCC Countries
14.2.2. South Africa
14.2.3. Rest of MEA
14.3.Market Value (US$ Mn) Forecast By Country, 2018–2028
14.4.Historical Market Value (US$ Mn) Trend Analysis By Drug Class, 2013–2017
14.4.1. Opioids
14.4.2. NSAIDs
14.4.3. Local Anesthetics
14.4.4. Acetaminophen
14.5.Market Value (US$ Mn) Forecast By Drug Class, 2018–2028
14.6.Historical Market Value (US$ Mn) Trend Analysis By Pain Type, 2013–2017
14.6.1. Surgical Pain
14.6.2. Cancer Pain
14.6.3. Neuropathic Pain
14.6.4. Others
14.7.Market Value (US$ Mn) Forecast By Pain Type, 2018–2028
14.8.Historical Market Value (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
14.8.1. Injectable
14.8.2. Oral
14.8.3. Topical
14.8.4. Transdermal
14.8.5. Others
14.9.Market Value (US$ Mn) Forecast By Route of Administration, 2018–2028
14.10. Historical Market Value (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
14.10.1. Hospital Pharmacies
14.10.2. Retail Pharmacies
14.10.3. Drug Store
14.10.4. Clinics
14.10.5. Others
14.11. Market Value (US$ Mn) Forecast By Distribution Channel, 2018–2028
14.12. Market Attractiveness Analysis
14.12.1. By Country
14.12.2. By Drug Class
14.12.3. By Pain Type
14.12.4. By Route of Administration
14.12.5. By Distribution Channel
14.13. Drivers and Restraints – Impact Analysis
15. Forecast Factors: Relevance and Impact
16. Forecast Assumptions
17. Competition Analysis
17.1.Competition Dashboard
17.2.Market Structure
17.3.Company Deep Dive
17.3.1. Teva Pharmaceutical Industries Ltd
17.3.1.1. Overview
17.3.1.2. Product and Application Portfolio
17.3.1.3. Production Footprint
17.3.1.4. Sales Footprint
17.3.1.5. Channel Footprint
17.3.1.6. Strategy
17.3.1.6.1. Marketing Strategy
17.3.1.6.2. Product Strategy
17.3.1.6.3. Channel Strategy
17.3.2. Novartis AG
17.3.2.1. Overview
17.3.2.2. Product and Application Portfolio
17.3.2.3. Production Footprint
17.3.2.4. Sales Footprint
17.3.2.5. Channel Footprint
17.3.2.6. Strategy
17.3.2.6.1. Marketing Strategy
17.3.2.6.2. Product Strategy
17.3.2.6.3. Channel Strategy
17.3.3. Allergan plc
17.3.3.1. Overview
17.3.3.2. Product and Application Portfolio
17.3.3.3. Production Footprint
17.3.3.4. Sales Footprint
17.3.3.5. Channel Footprint
17.3.3.6. Strategy
17.3.3.6.1. Marketing Strategy
17.3.3.6.2. Product Strategy
17.3.3.6.3. Channel Strategy
17.3.4. Pfizer Inc.
17.3.4.1. Overview
17.3.4.2. Product and Application Portfolio
17.3.4.3. Production Footprint
17.3.4.4. Sales Footprint
17.3.4.5. Channel Footprint
17.3.4.6. Strategy
17.3.4.6.1. Marketing Strategy
17.3.4.6.2. Product Strategy
17.3.4.6.3. Channel Strategy
17.3.5. Mylan N.V
17.3.5.1. Overview
17.3.5.2. Product and Application Portfolio
17.3.5.3. Production Footprint
17.3.5.4. Sales Footprint
17.3.5.5. Channel Footprint
17.3.5.6. Strategy
17.3.5.6.1. Marketing Strategy
17.3.5.6.2. Product Strategy
17.3.5.6.3. Channel Strategy
17.3.6. Egalet Corporation
17.3.6.1. Overview
17.3.6.2. Product and Application Portfolio
17.3.6.3. Production Footprint
17.3.6.4. Sales Footprint
17.3.6.5. Channel Footprint
17.3.6.6. Strategy
17.3.6.6.1. Marketing Strategy
17.3.6.6.2. Product Strategy
17.3.6.6.3. Channel Strategy
17.3.7. Pacira Pharmaceuticals
17.3.7.1. Overview
17.3.7.2. Product and Application Portfolio
17.3.7.3. Production Footprint
17.3.7.4. Sales Footprint
17.3.7.5. Channel Footprint
17.3.7.6. Strategy
17.3.7.6.1. Marketing Strategy
17.3.7.6.2. Product Strategy
17.3.7.6.3. Channel Strategy
17.3.8. Purdue Pharma L.P
17.3.8.1. Overview
17.3.8.2. Product and Application Portfolio
17.3.8.3. Production Footprint
17.3.8.4. Sales Footprint
17.3.8.5. Channel Footprint
17.3.8.6. Strategy
17.3.8.6.1. Marketing Strategy
17.3.8.6.2. Product Strategy
17.3.8.6.3. Channel Strategy
17.3.9. Endo International plc
17.3.9.1. Overview
17.3.9.2. Product and Application Portfolio
17.3.9.3. Production Footprint
17.3.9.4. Sales Footprint
17.3.9.5. Channel Footprint
17.3.9.6. Strategy
17.3.9.6.1. Marketing Strategy
17.3.9.6.2. Product Strategy
17.3.9.6.3. Channel Strategy
17.3.10. Janssen Pharmaceuticals, Inc.
17.3.10.1. Overview
17.3.10.2. Product and Application Portfolio
17.3.10.3. Production Footprint
17.3.10.4. Sales Footprint
17.3.10.5. Channel Footprint
17.3.10.6. Strategy
17.3.10.6.1. Marketing Strategy
17.3.10.6.2. Product Strategy
17.3.10.6.3. Channel Strategy
18. Global Analgesics Market Analysis 2013–2017 and Forecast 2018–2028, By Region
18.1.Introduction / Key Findings
18.2.Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2017
18.2.1. North America
18.2.2. Western Europe
18.2.3. Eastern Europe
18.2.4. Latin America
18.2.5. Asia Pacific excluding Japan and China
18.2.6. Japan
18.2.7. China
18.2.8. Middle East and Africa
18.3.Market Size (US$ Mn) Forecast By Region, 2018–2028
18.4.Market Attractiveness Analysis By Region
19. Global Analgesics Market Analysis 2013–2017 and Forecast 2018–2028, By Drug Class
19.1.Introduction
19.2.Historical Market Value (US$ Mn) Trend Analysis By Drug Class, 2013–2017
19.2.1. Opioids
19.2.2. NSAIDs
19.2.3. Local Anesthetics
19.2.4. Acetaminophen
19.3.Market Value (US$ Mn) Forecast By Drug Class, 2018–2028
19.4.Market Attractiveness Analysis By Drug Class
20. Global Analgesics Market Analysis 2013–2017 and Forecast 2018–2028, By Pain Type
20.1.Introduction
20.2.Historical Market Value (US$ Mn) Trend Analysis By Pain Type, 2013–2017
20.2.1. Surgical Pain
20.2.2. Cancer Pain
20.2.3. Neuropathic Pain
20.2.4. Others
20.3.Market Value (US$ Mn) Forecast By Pain Type, 2018–2028
20.4. Market Attractiveness Analysis By Pain Type
21. Global Analgesics Market Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration
21.1.Introduction
21.2.Historical Market Value (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
21.2.1. Injectable
21.2.2. Oral
21.2.3. Topical
21.2.4. Transdermal
21.2.5. Others
21.3.Market Value (US$ Mn) Forecast By Route of Administration, 2018–2028
21.4. Market Attractiveness Analysis By Route of Administration
22. Global Analgesics Market Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel
22.1.Introduction
22.2.Historical Market Value (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
22.2.1. Hospital Pharmacies
22.2.2. Retail Pharmacies
22.2.3. Drug Store
22.2.4. Clinics
22.2.5. Others
22.3.Market Value (US$ Mn) Forecast By Distribution Channel, 2018–2028
22.4.Market Attractiveness Analysis By Distribution Channel
23. Global Analgesics Market Analysis 2013–2017 and Forecast 2018–2028
23.1.Market Value Share Analysis
23.2.Y-o-Y Growth Analysis
23.3.Absolute $ Opportunity
24. Research Methodology
Analgesics Market Reports - List of Tables
Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 03 : North America Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 04 : North America Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 05 : North America Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Pain Type
Table 06 : North America Prescription Analgesics Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2028, By Distribution Channel
Table 07 : North America OTC Analgesics Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2028, By Distribution Channel
Table 08 : Latin America Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 09 : Latin America Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 10 : Latin America Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Pain Type
Table 11 : Latin America Prescription Analgesics Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2028, By Distribution Channel
Table 12 : Latin America OTC Analgesics Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2028, By Distribution Channel
Table 13 : Western Europe Prescription Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 14 : Western Europe OTC Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 15 : Western Europe Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 16 : Western Europe Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Pain Type
Table 17 : Western Europe Prescription Analgesics Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2028, By Distribution Channel
Table 18 : Western Europe OTC Analgesics Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2028, By Distribution Channel
Table 19 : Eastern Europe Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 20 : Eastern Europe Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 21 : Eastern Europe Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Pain Type
Table 22 : Eastern Europe Prescription Analgesics Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2028, By Distribution Channel
Table 23 : Eastern Europe OTC Analgesics Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2028, By Distribution Channel
Table 24 : Eastern Europe Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 25 : Asia-Pacific Excluding China & Japan Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 26 : Asia-Pacific Excluding China & Japan Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Pain Type
Table 27 : Asia-Pacific Excluding China & Japan Prescription Analgesics Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2028, By Distribution Channel
Table 28 : Asia-Pacific Excluding China & Japan OTC Analgesics Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2028, By Distribution Channel
Table 29 : China Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 30 : Asia-Pacific Excluding China & Japan Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Pain Type
Table 31 : China Prescription Analgesics Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2028, By Distribution Channel
Table 32 : China Prescription Analgesics Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2028, By Distribution Channel
Table 33 : Japan Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 34 : Japan Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Pain Type
Table 35 : Japan Prescription Analgesics Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2028, By Distribution Channel
Table 36 : Japan Prescription Analgesics Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2028, By Distribution Channel
Table 37 : Middle East & Africa Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 38 : Middle East & Africa Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 39 : Middle East & Africa Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Pain Type
Table 40 : Middle East & Africa Prescription Analgesics Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2028, By Distribution Channel
Table 41 : Middle East & Africa Prescription Analgesics Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2028, By Distribution Channel
Table 42 : Global Prescription Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Region
Table 43 : Global OTC Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Region
Table 44 : Global Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 45 : Global Analgesics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Pain Type
Table 46 : Global Prescription Analgesics Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2028, By Distribution Channel
Table 47 : Global OTC Analgesics Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2028, By Distribution Channel
Analgesics Market Reports - List of Figures
Figure 01 : Global Analgesics Market value (US$ Mn) Forecast, 2018 – 2028
Figure 02 : Global Analgesics Market Share, By Drug Class (2018)
Figure 03 : Global Analgesics Market Share, By Region (2018)
Figure 04: Global Healthcare Expenditure in US$ Tn (2013–2020)
Figure 05 : North America Analgesics Market Share, By Drug Class (2018 E)
Figure 06 : North America Analgesics Market Share, By Pain Type (2018 E)
Figure 07 : North America Analgesics Market Share, By Distribution Channel (2018 E)
Figure 08 : North America Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 09 : North America Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 10 : North America OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 11 : North America OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 12 : US Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 13 : US Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 14 : US OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 15 : US OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 16 : Canada Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 17 : Canada Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 18 : Canada OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 19 : Canada OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 20 : North America Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Opioids
Figure 21 : North America Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription Opioids
Figure 22 : North America Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription NSAIDs
Figure 23 : North America Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription NSAIDs
Figure 24 : North America Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC NSAIDs
Figure 25 : North America Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC NSAIDs
Figure 26 : North America Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Local Anaesthetics
Figure 27 : North America Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription Local Anaesthetics
Figure 28 : North America Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC Local Anaesthetics
Figure 29 : North America Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC Local Anaesthetics
Figure 30 : North America Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Acetaminophen
Figure 31 : North America Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription Acetaminophen
Figure 32 : North America Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC Acetaminophen
Figure 33 : North America Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC Acetaminophen
Figure 34 : North America Prescription Analgesics Market Attractiveness Analysis, , By Country
Figure 35 : North America Prescription Analgesics Market Attractiveness Analysis, By Drug Class
Figure 36: North America Prescription Analgesics Market Attractiveness Analysis, , By Pain Type
Figure 37 : North America Prescription Analgesics Market Attractiveness Analysis, By Distribution Channel
Figure 38 : North America OTC Analgesics Market Attractiveness Analysis, By Country
Figure 39 : North America OTC Analgesics Market Attractiveness Analysis, By Drug Class
Figure 40 : North America OTC Analgesics Market Attractiveness Analysis, , By Pain Type
Figure 41 : North America OTC Analgesics Market Attractiveness Analysis, By Distribution Channel
Figure 42 : Latin America Analgesics Market Share, By Drug Class (2018)
Figure 43 : Latin America Analgesics Market Share, By Pain Type (2018)
Figure 44 : Latin America Analgesics Market Share, By Distribution Channel (2018)
Figure 45 : Latin America Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 46 : Latin America Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 47 : Latin America OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 48 : Latin America OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 49 : Brazil Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 50 : Brazil Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 51 : Brazil OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 52 : Brazil OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 53 : Mexico Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 54 : Mexico Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 55 : Mexico OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 56 : Mexico OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 57 : Rest of Latin America Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 58 : Rest of Latin America Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 59 : Rest of Latin America OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 60 : Rest of Latin America OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 61 : Latin America Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Opioids
Figure 62 : Latin America Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Opioids
Figure 63 : Latin America Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription NSAIDs
Figure 64 : Latin America Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription NSAIDs
Figure 65 : Latin America Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC NSAIDs
Figure 66 : Latin America Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC NSAIDs
Figure 67 : Latin America Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Local Anaesthetics
Figure 68 : Latin America Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription Local Anaesthetics
Figure 69 : Latin America Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC Local Anaesthetics
Figure 70 : Latin America Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC Local Anaesthetics
Figure 71 : Latin America Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Acetaminophen
Figure 72 : Latin America Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription Acetaminophen
Figure 73 : Latin America Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC Acetaminophen
Figure 74 : Latin America Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC Acetaminophen
Figure 75 : Latin America Prescription Analgesics Market Attractiveness Analysis, , By Country
Figure 76 : Latin America Prescription Analgesics Market Attractiveness Analysis, By Drug Class
Figure 77 : Latin America Prescription Analgesics Market Attractiveness Analysis, , By Pain Type
Figure 78 : Latin America Prescription Analgesics Market Attractiveness Analysis, By Distribution Channel
Figure 79 : Latin America OTC Analgesics Market Attractiveness Analysis, , By Country
Figure 80 : Latin America OTC Analgesics Market Attractiveness Analysis, By Drug Class
Figure 81 : Latin America OTC Analgesics Market Attractiveness Analysis, , By Pain Type
Figure 82 : Latin America OTC Analgesics Market Attractiveness Analysis, By Distribution Channel
Figure 83 : Western Europe Analgesics Market Share, By Drug Class (2018 E)
Figure 84 : Western Europe Analgesics Market Share, By Pain Type (2018 E)
Figure 85 : Western Europe Analgesics Market Share, By Distribution Channel (2018 E)
Figure 86 : Western Europe Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 87 : Western Europe Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 88 : Western Europe OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 89 : Western Europe OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 90 : Germany Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 91 : Germany Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 92 : Germany OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 93 : Germany OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 94 : U.K. Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 95 : U.K. Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 96 : U.K. OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 97 : U.K. OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 98 : Italy Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 99 :Italy Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 100 : Italy OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 101 : Italy OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 102 : Spain Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 103 : Spain Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 104 : Spain OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 105 : Spain OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 106: France Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 107 :France Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 108 : France OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 109 : France OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 110 : Benelux Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 111 : Benelux Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 112 : Benelux OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 113 : Benelux OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 114 : Nordic Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 115 : Nordic Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 116 : Nordic OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 117 : Nordic OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 118 : Rest of Western Europe Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 119 : Rest of Western Europe Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 120 : Rest of Western Europe OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 121 : Rest of Western Europe OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 122 : Western Europe Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Opioids
Figure 123 : Western Europe Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Opioids
Figure 124 : Western Europe Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription NSAIDs
Figure 125 : Western Europe Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription NSAIDs
Figure 126 : Western Europe Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC NSAIDs
Figure 127 : Western Europe Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC NSAIDs
Figure 128 : Western Europe Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Local Anaesthetics
Figure 129 : Western Europe Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription Local Anaesthetics
Figure 130 : Western Europe Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC Local Anaesthetics
Figure 131 : Western Europe Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC Local Anaesthetics
Figure 132 : Western Europe Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Acetaminophen
Figure 133 : Western Europe Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription Acetaminophen
Figure 134 : Western Europe Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC Acetaminophen
Figure 135 : Western Europe Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC Acetaminophen
Figure 136 : Western Europe Prescription Analgesics Market Attractiveness Analysis, , By Country
Figure 137 : Western Europe Prescription Analgesics Market Attractiveness Analysis, By Drug Class
Figure 138 : Western Europe Prescription Analgesics Market Attractiveness Analysis, , By Pain Type
Figure 139 : Western Europe Prescription Analgesics Market Attractiveness Analysis, By Distribution Channel
Figure 140 : Western Europe OTC Analgesics Market Attractiveness Analysis, , By Country
Figure 141 : Western Europe OTC Analgesics Market Attractiveness Analysis, By Drug Class
Figure 142 : Western Europe OTC Analgesics Market Attractiveness Analysis, , By Pain Type
Figure 143 : Western Europe OTC Analgesics Market Attractiveness Analysis, By Distribution Channel
Figure 144 : Eastern Europe Analgesics Market Share, By Drug Class (2018 E)
Figure 145 : Eastern Europe Analgesics Market Share, By Pain Type (2018 E)
Figure 146 : Eastern Europe Analgesics Market Share, By Distribution Channel (2018 E)
Figure 147 : Eastern Europe Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 148 : Eastern Europe Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 149 : Eastern Europe OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 150 : Eastern Europe OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 151: Russia Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 152 : Russia Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 153 : Russia OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 154 : Russia OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 155 : Poland Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 156 : Poland Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 157 : Poland OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 158 : Poland OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 159 : Rest of Eastern Europe Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 160 : Rest of Eastern Europe Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 161 : Rest of Eastern Europe OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 162 : Rest of Eastern Europe OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 163 : Eastern Europe Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Opioids
Figure 164 : Eastern Europe Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Opioids
Figure 165 : Eastern Europe Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription NSAIDs
Figure 166 : Eastern Europe Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription NSAIDs
Figure 167 : Eastern Europe Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC NSAIDs
Figure 168 : Eastern Europe Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC NSAIDs
Figure 169 : Eastern Europe Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Local Anaesthetics
Figure 170 : Eastern Europe Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription Local Anaesthetics
Figure 171 : Eastern Europe Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC Local Anaesthetics
Figure 172 : Eastern Europe Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC Local Anaesthetics
Figure 173 : Eastern Europe Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Acetaminophen
Figure 174 : Eastern Europe Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription Acetaminophen
Figure 175 : Eastern Europe Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC Acetaminophen
Figure 176 : Eastern Europe Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC Acetaminophen
Figure 177 : Eastern Europe Prescription Analgesics Market Attractiveness Analysis, , By Country
Figure 178 : Eastern Europe Prescription Analgesics Market Attractiveness Analysis, By Drug Class
Figure 179 : Eastern Europe Prescription Analgesics Market Attractiveness Analysis, , By Pain Type
Figure 180 : Eastern Europe Prescription Analgesics Market Attractiveness Analysis, By Distribution Channel
Figure 181 : Eastern Europe OTC Analgesics Market Attractiveness Analysis, , By Country
Figure 182 : Eastern Europe OTC Analgesics Market Attractiveness Analysis, By Drug Class
Figure 183 : Eastern Europe OTC Analgesics Market Attractiveness Analysis, , By Pain Type
Figure 184 : Eastern Europe OTC Analgesics Market Attractiveness Analysis, By Distribution Channel
Figure 185 : Asia-Pacific Excluding China & Japan Analgesics Market Share, By Drug Class (2018)
Figure 186 : Asia-Pacific Excluding China & Japan Analgesics Market Share, By Pain Type (2018)
Figure 187 : Asia-Pacific Excluding China & Japan Analgesics Market Share, By Distribution Channel (2018)
Figure 188 : Asia-Pacific Excluding China & Japan Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 189 : Asia-Pacific Excluding China & Japan Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 190 : Asia-Pacific Excluding China & Japan OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 191 : Asia-Pacific Excluding China & Japan OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 192 : Australia and New Zealand Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 193 : Australia and New Zealand Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 194 : Australia & New Zealand OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 195 : Australia & New Zealand OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 196 : India Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 197 : India Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 198 : India OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 199 : India OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 200 : Rest of Asia-Pacific Excluding China & Japan Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 201 : Rest of Asia-Pacific Excluding China & Japan Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 202 : Rest of Asia-Pacific Excluding China & Japan OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 203 : Rest of Asia-Pacific Excluding China & Japan OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 204 : Asia-Pacific Excluding China & Japan Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Opioids
Figure 205 : Asia-Pacific Excluding China & Japan Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Opioids
Figure 206 : Asia-Pacific Excluding China & Japan Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription NSAIDs
Figure 207 : Asia-Pacific Excluding China & Japan Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription NSAIDs
Figure 208 : Asia-Pacific Excluding China & Japan Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC NSAIDs
Figure 209 : Asia-Pacific Excluding China & Japan Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC NSAIDs
Figure 210 : Asia-Pacific Excluding China & Japan Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Local Anaesthetics
Figure 211: Asia-Pacific Excluding China & Japan Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription Local Anaesthetics
Figure 212 : Asia-Pacific Excluding China & Japan Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC Local Anaesthetics
Figure 213 : Asia-Pacific Excluding China & Japan Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC Local Anaesthetics
Figure 214 : Asia-Pacific Excluding China & Japan Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Acetaminophen
Figure 215 : Asia-Pacific Excluding China & Japan Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription Acetaminophen
Figure 216 : Asia-Pacific Excluding China & Japan Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC Acetaminophen
Figure 217 : Asia-Pacific Excluding China & Japan Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC Acetaminophen
Figure 218 : Asia-Pacific Excluding China & Japan Prescription Analgesics Market Attractiveness Analysis, , By Country
Figure 219 : Asia-Pacific Excluding China & Japan Prescription Analgesics Market Attractiveness Analysis, By Drug Class
Figure 220 : Asia-Pacific Excluding China & Japan Prescription Analgesics Market Attractiveness Analysis, , By Pain Type
Figure 221 : Asia-Pacific Excluding China & Japan Prescription Analgesics Market Attractiveness Analysis, By Distribution Channel
Figure 222 : Asia-Pacific Excluding China & Japan OTC Analgesics Market Attractiveness Analysis, , By Country
Figure 223 : Asia-Pacific Excluding China & Japan OTC Analgesics Market Attractiveness Analysis, By Drug Class
Figure 224 : Asia-Pacific Excluding China & Japan OTC Analgesics Market Attractiveness Analysis, , By Pain Type
Figure 225 : Asia-Pacific Excluding China & Japan OTC Analgesics Market Attractiveness Analysis, By Distribution Channel
Figure 226 : China Analgesics Market Share, By Drug Class (2018)
Figure 227 : China Analgesics Market Share, By Pain Type (2018)
Figure 228 : China Analgesics Market Share, By Distribution Channel (2018)
Figure 229 : China Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 230 : China Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 231 : China OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 232 : China OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 233 : China Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Opioids
Figure 234 : China Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Opioids
Figure 235 : China Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription NSAIDs
Figure 236 : China Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription NSAIDs
Figure 237 : China Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC NSAIDs
Figure 238 : China Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC NSAIDs
Figure 239 : China Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Local Anaesthetics
Figure 240 : China Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription Local Anaesthetics
Figure 241 : China Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC Local Anaesthetics
Figure 242 : China Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC Local Anaesthetics
Figure 243 : China Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Acetaminophen
Figure 244 : China Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription Acetaminophen
Figure 245 : China Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC Acetaminophen
Figure 246 : China Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC Acetaminophen
Figure 247 : China Prescription Analgesics Market Attractiveness Analysis, , By Drug Class
Figure 248 : China Prescription Analgesics Market Attractiveness Analysis, By Pain Type
Figure 249 : China Prescription Analgesics Market Attractiveness Analysis, By Distribution Channel
Figure 250 : China OTC Analgesics Market Attractiveness Analysis, , By Drug Class
Figure 251 : China OTC Analgesics Market Attractiveness Analysis, By Pain Type
Figure 252 : China OTC Analgesics Market Attractiveness Analysis, By Distribution Channel
Figure 253 : Japan Analgesics Market Share, By Drug Class (2018)
Figure 254 : Japan Analgesics Market Share, By Pain Type (2018)
Figure 255 : Japan Analgesics Market Share, By Distribution Channel (2018)
Figure 256 : Japan Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 257 : Japan Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 258 : Japan OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 259 : Japan OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 260: Japan Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Opioids
Figure 261 : Japan Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Opioids
Figure 262 : Japan Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription NSAIDs
Figure 263 : Japan Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription NSAIDs
Figure 264 : Japan Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC NSAIDs
Figure 265 : Japan Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC NSAIDs
Figure 266 : Japan Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Local Anaesthetics
Figure 267 : Japan Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription Local Anaesthetics
Figure 268 : Japan Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC Local Anaesthetics
Figure 269 : Japan Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC Local Anaesthetics
Figure 270 : Japan Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Acetaminophen
Figure 271 : Japan Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription Acetaminophen
Figure 272 : Japan Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC Acetaminophen
Figure 273 : Japan Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC Acetaminophen
Figure 274 : Japan Prescription Analgesics Market Attractiveness Analysis, , By Drug Class
Figure 275 : Japan Prescription Analgesics Market Attractiveness Analysis, By Pain Type
Figure 276 : Japan Prescription Analgesics Market Attractiveness Analysis, By Distribution Channel
Figure 277 : Japan OTC Analgesics Market Attractiveness Analysis, , By Drug Class
Figure 278 : Japan OTC Analgesics Market Attractiveness Analysis, By Pain Type
Figure 279 : Japan OTC Analgesics Market Attractiveness Analysis, By Distribution Channel
Figure 280 : Middle East & Africa Analgesics Market Share, By Drug Class (2018)
Figure 281 : Middle East & Africa Analgesics Market Share, By Pain Type (2018)
Figure 282 : Middle East & Africa Analgesics Market Share, By Distribution Channel (2018)
Figure 283 : Middle East & Africa Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 284 : Middle East & Africa Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 285 : Middle East & Africa OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 286 : Middle East & Africa OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 287 : GCC Countries Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 288 : GCC Countries Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 289 : GCC Countries OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 290 : GCC Countries OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 291 : South Africa Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 292 : South Africa Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 293 : South Africa OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 294 : South Africa OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 295 : Rest of Middle East & Africa Prescription Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 296 : Rest of Middle East & Africa Prescription Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 297 : Rest of Middle East & Africa OTC Analgesics Market Size (US$ Mn) Analysis, 2013–2017
Figure 298 : Rest of Middle East & Africa OTC Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 299 : Middle East & Africa Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Opioids
Figure 300 : Middle East & Africa Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Opioids
Figure 301 : Middle East & Africa Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription NSAIDs
Figure 302 : Middle East & Africa Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription NSAIDs
Figure 303 : Middle East & Africa Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC NSAIDs
Figure 304 : Middle East & Africa Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC NSAIDs
Figure 305 : Middle East & Africa Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Local Anaesthetics
Figure 306 : Middle East & Africa Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription Local Anaesthetics
Figure 307 : Middle East & Africa Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC Local Anaesthetics
Figure 308 : Middle East & Africa Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC Local Anaesthetics
Figure 309 : Middle East & Africa Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Acetaminophen
Figure 310 : Middle East & Africa Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By Prescription Acetaminophen
Figure 311 : Middle East & Africa Analgesics Market Size (US$ Mn) Analysis, 2013–2017, By OTC Acetaminophen
Figure 312 : Middle East & Africa Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028, By OTC Acetaminophen
Figure 313 : Middle East & Africa Prescription Analgesics Market Attractiveness Analysis, , By Country
Figure 314 : Middle East & Africa Prescription Analgesics Market Attractiveness Analysis, By Drug Class
Figure 315 : Middle East & Africa Prescription Analgesics Market Attractiveness Analysis, , By Pain Type
Figure 316 : Middle East & Africa Prescription Analgesics Market Attractiveness Analysis, By Distribution Channel
Figure 317 : Middle East & Africa OTC Analgesics Market Attractiveness Analysis, , By Country
Figure 318 : Middle East & Africa OTC Analgesics Market Attractiveness Analysis, By Drug Class
Figure 319 : Middle East & Africa OTC Analgesics Market Attractiveness Analysis, , By Pain Type
Figure 320 : Middle East & Africa OTC Analgesics Market Attractiveness Analysis, By Distribution Channel
Figure 321 : Global Prescription Analgesics Market Value (US$ Mn), By Region, 2018 & 2028
Figure 322 : Global Prescription Analgesics Market Value (US$ Mn), By Region, 2018 & 2028
Figure 323 : Global Analgesics Market Attractiveness Analysis, By Region
Figure 324 : Global Analgesics Market Attractiveness Analysis, By Region
Figure 325 : Global Prescription Analgesics Market Value (US$ Mn), By Drug Class, 2018 & 2028
Figure 326 : Global Prescription Analgesics Market Value (US$ Mn), By Drug Class, 2018 & 2028
Figure 327 : Global Prescription Analgesics Market Attractiveness Analysis, By Drug Class
Figure 328 : Global Analgesics Market Attractiveness Analysis, By Drug Class
Figure 329 : Global Prescription Analgesics Market Value (US$ Mn), By Pain Type, 2018 & 2028
Figure 330 :Global Prescription Analgesics Market Value (US$ Mn), By Pain Type, 2018 & 2028
Figure 331 : Global Prescription Analgesics Market Attractiveness Analysis, By Pain Type
Figure 332 : Global OTC Analgesics Market Attractiveness Analysis, By Pain Type
Figure 333 : Global Prescription Analgesics Market Value (US$ Mn), By Region, 2018 & 2028
Figure 334 :Global Prescription Analgesics Market Value (US$ Mn), By Region, 2018 & 2028
Figure 335 : Global Prescription Analgesics Market Attractiveness Analysis, By Distribution Channel
Figure 336 : Global OTC Analgesics Market Attractiveness Analysis, By Distribution Channel
Figure 337 : Global Analgesics Historical Market Size and Y-o-Y, 2013- 2017, By Prescription Analgesics
Figure 338 : Global Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By Prescription Analgesics
Figure 339 : Global Analgesics Market Absolute $ Opportunity, 2013–2028, By Region for Prescription Analgesics
Figure 340 : Global Analgesics Historical Market Size and Y-o-Y, 2013- 2017, By OTC Analgesics
Figure 341 : Global Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028, By OTC Analgesics
Figure 342 : Global Analgesics Market Absolute $ Opportunity, 2013–2028, By Region for OTC Analgesics